View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Quest Diagnostics Inc: 1 director

A director at Quest Diagnostics Inc sold 1,748 shares at 175.515USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

S&P 500 and Nasdaq 100 Testing Prior 2022 Highs Since late-February (2/25/25 Compass) we expected an 8-10% pullback to provide a buying opportunity. But that all changed in last week's Compass (4/1/25), when we downgraded our outlook to bearish/cautious, citing several concerning developments (SPX and QQQ failure at 200-day MAs, bear flag breakdowns across major indexes targeting 5100-5200 on SPX, high yield spreads widening above 355bps, major tops on market leaders NVDA and META, semiconducto...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Quest Diagnostics Incorporated and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 3 April 2025 in which we reassessed the appropriateness of the ratings in th...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Growth Leading This EOY Rally; Expect More Upside Our outlook remains bullish and we see the market in the midst of a significant end-of-year rally that we have been expecting since mid-October. We continue to expect support at the 20-day MAs on the S&P 500 and Nasdaq 100 (QQQ), while support at current levels or the 50-day MA is likely on the Russell 2000 (IWM). Ultimately, we will remain bullish as long as the S&P 500 is above 5850. Market dynamics continue to improve, giving us confidence th...

Extreme Networks Inc: 1 director

A director at Extreme Networks Inc sold 37,000 shares at 17.472USD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Moody's Ratings assigns Baa1 rating to Quest Diagnostics Incorporated'...

Moody's Ratings (Moodys) assigned a Baa1 rating to Quest Diagnostics Incorporated' ("Quest") proposed offering of senior unsecured notes. Quest intends to use the net proceeds from this offering to fund the recently announced acquisition of LifeLabs (a Canadian provider of community laboratory tests...

Quest Diagnostics Incorporated: Update to credit analysis

Our credit view of this issuer reflects its considerable scale and low financial leverage, constrained by its history of shareholder-friendly policies.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Moody's Ratings upgrades Quest Diagnostics' senior unsecured debt rati...

Moody's Ratings (Moody's) upgraded the senior unsecured debt ratings of Quest Diagnostics Incorporated ("Quest") to Baa1 from Baa2. Moody's also upgraded the rating on the company's senior unsecured shelf registration to (P)Baa1 from (P) Baa2. The outlook was changed to stable from positive.        ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Moody's assigns Baa2 rating to Quest Diagnostics' notes offering; posi...

Moody's Investors Service ("Moody's") assigned a Baa2 rating to the proposed offering of senior unsecured notes of Quest Diagnostics Incorporated ("Quest"). There are no changes to Moody's existing ratings of Quest including the Baa2 senior unsecured long-term ratings. The outlook remains unchanged ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

n this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Quest Diagnostics Incorporated: Update of our credit view following re...

Our credit view of this issuer reflects its considerable scale and low financial leverage, offset by its significant cash deployed to shareholders.

Moody's affirms Quest Diagnostics Incorporated at Baa2; revises outloo...

Moody's Investors Service ("Moody's") affirmed the senior unsecured ratings of Quest Diagnostics Incorporated ("Quest") at Baa2. At the same time, Moody's revised the outlook to positive from stable. The revision in outlook to positive reflects Moody's expectation for solid operating performance w...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Quest Diagnostics Incorporated: Solid performance continues as revenue...

Our credit view of this issuer reflects its considerable scale and low financial leverage, offset by its significant cash deployed to shareholders.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch